ST. Jude Laboratories LLC

ST. Jude Laboratories LLC was paid $2.08M by Medicaid between Jul 2019 and Dec 2024, across 44 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 65% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Maryland

Rank by total paid#30 of 93

Median peer was paid$430K

This provider vs. median4.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	15	$771.00
2020	2,587	$189K
2021	21,695	$637K
2022	22,505	$653K
2023	15,623	$392K
2024incomplete	7,301	$205K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	65%	22,644	9,738	$1.36M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	16%	3,777	3,278	$339K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	7.9%	17,620	7,523	$163K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	5.9%	4,011	3,364	$123K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	2.4%	4,683	2,051	$51K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	317	239	$12K
87641		<1%	3,339	2,882	$9K
87278		<1%	2,673	2,321	$4K
86317		<1%	2,673	2,321	$4K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	15	14	$3K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	505	430	$3K
87486		<1%	355	308	$2K

32 more codes

87529		<1%	356	$1K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	364	$1K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	363	$1K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	15	$771.00
87109		<1%	548	$767.78
87660		<1%	351	$460.17
86695		<1%	351	$449.19
87563		<1%	356	$422.04
87581		<1%	103	$378.49
87500		<1%	138	$363.47
86780		<1%	370	$337.74
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	550	$319.02
87510		<1%	333	$299.28
36415	Collection of venous blood by venipuncture	<1%	127	$262.90
80053	Comprehensive metabolic panel	<1%	414	$249.56
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	105	$174.36
87653		<1%	131	$163.99
87480		<1%	133	$140.90
84443	Thyroid stimulating hormone (TSH)	<1%	138	$125.40
80061	Lipid panel	<1%	155	$115.63
80048	Basic metabolic panel (calcium, ionized)	<1%	350	$105.41
87185		<1%	139	$91.13
83036	Hemoglobin; glycosylated (A1C)	<1%	181	$83.86
G0471	Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)	<1%	538	$58.00
85027		<1%	73	$24.73
81001		<1%	111	$21.53
83735		<1%	35	$17.73
82607		<1%	13	$14.79
82746		<1%	12	$14.43
87631		0%	46	$0.00
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	0%	15	$0.00
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	0%	200	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKALAMPANAYIL, BOSE (OWNER)